Single-dose methotrexate for the treatment of ectopic pregnancy: Our experience from 2010 to 2015
Author(s) -
Emre Erdem Taş,
Gülin Feykan Feykan Yeğin Akçay,
Ayşe Filiz Avşar
Publication year - 2017
Publication title -
pakistan journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.316
H-Index - 30
eISSN - 1682-024X
pISSN - 1681-715X
DOI - 10.12669/pjms.331.11238
Subject(s) - medicine , methotrexate , human chorionic gonadotropin , ectopic pregnancy , retrospective cohort study , cutoff , pregnancy , gastroenterology , odds ratio , urology , vaginal bleeding , obstetrics , gynecology , hormone , physics , quantum mechanics , biology , genetics
To evaluate the success of systemic single-dose methotrexate (MTX) treatment in patients with ectopic pregnancy (EP) and to investigate factors related to treatment success.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom